EMCDDA news
EMCDDA–Europol Joint Report on a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl)
EMCDDA Director visits Federal Office of Public Health, Switzerland
EMCDDA Director Alexis Goosdeel is in Switzerland today for a two-day meeting with representatives of the Federal Office of Public Health (FOPH).
23.02.2018
Read more
EMCDDA continues support for EU drug-related regional programme in Central Asia
The Central Asian Drug Action Programme (CADAP), is currently in its sixth phase and reflects the EU’s long-term engagement with Central Asian partners to help further strengthen their national policies in drug demand reduction.
22.02.2018
Read more
EMCDDA releases report on European environmental prevention measures to limit unhealthy and risky substance use behaviours
In a new report published today, Environmental substance use prevention interventions in Europe, the EMCDDA offers a first operational definition of the concept and an initial overview of where and how such interventions are being used in the region.
21.02.2018
Read more
Environmental substance use prevention interventions in Europe
EMCDDA makes first presentation before European Parliament public health committee
Today, EMCDDA Director Alexis Goosdeel is in Brussels for an exchange of views with the European Parliament’s Committee for Environment, Public Health and Food Safety (ENVI).
19.02.2018
Read more
Programming document 2018–20
Vermont state to legalise recreational cannabis
On 22 January 2018, Vermont became the ninth US state to legalise possession of cannabis for recreational purposes, when Governor Phil Scott (Republican) signed House Bill 511 (Text of Act as passed by House and Senate). The law will take effect on 1 July 2018. 06.02.2018
Read more
